Managing symptoms of irritable bowel syndrome in patients with inflammatory bowel disease

Gut

Volumn 60, Issue 4, 2011, Pages 425-428

  Camilleri, Michael ^a  

^a Clinical Enteric Neuroscience Translational and Epidemiological Research Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALGRANULIN; LACTOFERRIN;

ABDOMINAL PAIN; BACTERIAL OVERGROWTH; BILE ACID METABOLISM; BLOATING; BLOOD ANALYSIS; CAPSULE ENDOSCOPY; CELIAC DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CROHN DISEASE; DIARRHEA; DIFFERENTIAL DIAGNOSIS; FECES ANALYSIS; HUMAN; INTESTINAL DYSMOTILITY; IRRITABLE COLON; MALABSORPTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS INSUFFICIENCY; PELVIC ORGAN PROLAPSE; PRIORITY JOURNAL; REMISSION; REVIEW; ULCERATIVE COLITIS;

BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; DIARRHEA; HUMANS; INFLAMMATORY BOWEL DISEASES; IRRITABLE BOWEL SYNDROME;

EID: 79952537567     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2010.234583     Document Type: Review

References (45)

1. Halder SL, Locke GR3rd, Schleck CD, et al. Natural history of functional gastrointestinal disorders: a 12-year longitudinal population-based study. Gastroenterology 2007;133:799-807.
2. Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel disorders. Gastroenterology 2006;130:1480-91.
3. Loftus CG, Loftus EVJr, Harmsen WS, et al. Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000. Inflamm Bowel Dis 2007;13:254-61.
4. Kappelman MD, Rifas-Shiman SL, Kleinman K, et al. The prevalence and geographical distribution of Crohn's disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol 2007;5:1424-9. (Pubitemid 350181588)
5. Zaman MS, Robson KM, Lembo AJ. Overlap of irritable bowel syndrome (IBS) symptoms in patients with inflammatory bowel disease (IBD). Am J Gastroenterol 2002;97:S284.
6. Camilleri M. Do the symptom-based, Rome criteria of irritable bowel syndrome lead to better diagnosis and treatment outcomes? The con argument. Clin Gastroenterol Hepatol 2009;8:129.
7. Tibble JA, Sigthorsson G, Foster R, et al. Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease. Gastroenterology 2002;123:450-60. (Pubitemid 34827189)
8. Carroccio A, Iacono G, Cottone M, et al. Diagnostic accuracy of fecal calprotectin assay in distinguishing organic causes of chronic diarrhoea from irritable bowel syndrome: a prospective study in adults and children. Clin Chem 2003;49(6 Pt 1):861-7. (Pubitemid 36623463)
9. Kane SV, Sandborn WJ, Rufo PA, et al. Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation. Am J Gastroenterol 2003;98:1309-14. (Pubitemid 36741528)
10. Otten CM, Kok L, Witteman BJ, et al. Diagnostic performance of rapid tests for detection of fecal calprotectin and lactoferrin and their ability to discriminate inflammatory from irritable bowel syndrome. Clin Chem Lab Med 2008;46:1275-80.
11. Langhorst J, Junge A, Rueffer A, et al. Elevated human beta-defensin-2 levels indicate an activation of the innate immune system in patients with irritable bowel syndrome. Am J Gastroenterol 2009;104:404-10.
12. Schoepfer AM, Trummler M, Seeholzer P, et al. Discriminating IBD from IBS: comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies. Inflamm Bowel Dis 2008;14:32-9. (Pubitemid 351196866)
13. Schoepfer AM, Schaffer T, Seibold-Schmid B, et al. Antibodies to flagellin indicate reactivity to bacterial antigens in IBS patients. Neurogastroenterol Motil 2008;20:1110-18.
14. Manolakis AC, Kapsoritakis AN, Georgoulias P, et al. Moderate performance of serum S100A12, in distinguishing inflammatory bowel disease from irritable bowel syndrome. BMC Gastroenterol 2010;10:118.
15. Kaiser T, Langhorst J, Wittkowski H, et al. Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome. Gut 2007;56:1706-13. (Pubitemid 350206297)
16. Hara AK, Leighton JA, Heigh RI, et al. Crohn disease of the small bowel: preliminary comparison among CT enterography, capsule endoscopy, small-bowel follow-through, and ileoscopy. Radiology 2006;238:128-34. (Pubitemid 43010588)
17. Siddiki HA, Fidler JL, Fletcher JG, et al. Prospective comparison of state-of-the-art MR enterography and CT enterography in small-bowel Crohn's disease. AJR Am J Roentgenol 2009;193:113-21.
18. Fletcher JG, Huprich J, Loftus EVJr, et al. Computerized tomography enterography and its role in small-bowel imaging. Clin Gastroenterol Hepatol 2008;6:283-9. (Pubitemid 351318385)
19. Rimola J, Ordás I, Rodriguez S, et al. Magnetic resonance imaging for evaluation of Crohn's disease: Validation of parameters of severity and quantitative index of activity. Inflamm Bowel Dis. Published Online First: 8 Nov 2010. doi:10.1002/ibd.20551.
20. Hofmann AF, Poley JR. Cholestyramine treatment of diarrhea associated with ileal resection. N Engl J Med 1969;281:397-402.
21. Camilleri M, Nadeau A, Tremaine WJ, et al. Measurement of serum 7alpha-hydroxy-4-cholesten- 3-one (or 7alphaC4), a surrogate test for bile acid malabsorption in health, ileal disease and irritable bowel syndrome using liquid chromatography-tandem mass spectrometry. Neurogastroenterol Motil 2009;21:734-e43.
22. Lenicek M, Duricova D, Komarek V, et al. Bile acid malabsorption in inflammatory bowel disease: Assessment by serum markers. Inflamm Bowel Dis Published Online First: 5 Nov 2010.
23. Nyhlin H, Merrick MV, Eastwood MA. Bile acid malabsorption in Crohn's disease and indications for its assessment using SeHCAT. Gut 1994;35:90-3. (Pubitemid 24059479)
24. Walters JR, Tasleem AM, Omer OS, et al. A new mechanism for bile acid diarrhea: defective feedback inhibition of bile acid biosynthesis. Clin Gastroenterol Hepatol 2009;7:1189-94.
25. Annese V, Bassotti G, Napolitano G, et al. Gastrointestinal motility disorders in patients with inactive Crohn's disease. Scand J Gastroenterol 1997;32:1107-17. (Pubitemid 27523842)
26. Simrén M, Stotzer PO. Use and abuse of hydrogen breath tests. Gut 2006;55:297-303. (Pubitemid 43268261)
27. Klaus J, Spaniol U, Adler G, et al. Small intestinal bacterial overgrowth mimicking acute flare as a pitfall in patients with Crohn's Disease. BMC Gastroenterol 2009;9:61.
28. Rutgeerts P, Ghoos Y, Vantrappen G, et al. Ileal dysfunction and bacterial overgrowth in patients with Crohn's disease. J Clin Invest 1981;11:199-206. (Pubitemid 11002894)
29. Logan I, Bowlus CL. The geoepidemiology of autoimmune intestinal diseases. Autoimmun Rev 2010;9:A372-8.
30. Alam M, Shen B, Achkar JP, et al. Concurrent inflammatory bowel disease (IBD) and celiac disease (CeD): an aggressive form of IBD? Am J Gastroenterol 2003;98:S80-1.
31. Maconi G, Dominici R, Molteni M, et al. Prevalence of pancreatic insufficiency in inflammatory bowel diseases. Assessment by fecal elastase-1. Dig Dis Sci 2008;53:262-70. (Pubitemid 350265679)
32. Barthet M, Hastier P, Bernard JP, et al. Chronic pancreatitis and inflammatory bowel disease: true or coincidental association? Am J Gastroenterol 1999;94:2141-8.
33. Seyrig JA, Jian R, Modigliani R, et al. Idiopathic pancreatitis associated with inflammatory bowel disease. Dig Dis Sci 1985;30:1121-6. (Pubitemid 16132369)
34. Crowell MD, Lacy BE, Schettler VA, et al. Subtypes of anal incontinence associated with bowel dysfunction: clinical, physiologic, and psychosocial characterization. Dis Colon Rectum 2004;47:1627-35. (Pubitemid 39331973)
35. Shen B, Achkar JP, Lashner BA, et al. Irritable pouch syndrome: a new category of diagnosis for symptomatic patients with ileal pouch-anal anastomosis. Am J Gastroenterol 2002;97:972-7. (Pubitemid 34408256)
36. Shen B, Sanmiguel C, Bennett AE, et al. Irritable pouch syndrome is characterized by visceral hypersensitivity. Inflamm Bowel Dis. Published Online First 3 Aug 2010. doi:10.1002/ibd.21412.
37. Bernstein CN, Rollandelli R, Niazi N, et al. Characterization of afferent mechanisms in ileoanal pouches. Am J Gastroenterol 1997;92:103-8. (Pubitemid 27027038)
38. Chang L, Munakata J, Mayer EA, et al. Perceptual responses in patients with inflammatory and functional bowel disease. Gut 2000;47:497-505.
39. Rao SS, Read NW, Davison PA, et al. Anorectal sensitivity and responses to rectal distention in patients with ulcerative colitis. Gastroenterology 1987;93:1270-5. (Pubitemid 17167268)
40. Minderhoud IM, Oldenburg B, Wismeijer JA, et al. IBS-like symptoms in patients with inflammatory bowel disease in remission; relationships with quality of life and coping behavior. Dig Dis Sci 2004;49:469-74. (Pubitemid 38453568)
41. Simrén M, Axelsson J, Gillberg R, et al. Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors. Am J Gastroenterol 2002;97:389-96. (Pubitemid 34160766)
42. Keohane J, O'Mahony C, O'Mahony L, et al. Irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease: a real association or reflection of occult inflammation? Am J Gastroenterol 2010;105:1788-94.
43. Long MD, Drossman DA. Inflammatory bowel disease, irritable bowel syndrome, or what? A challenge to the functional-organic dichotomy. Am J Gastroenterol 2010;105:1796-8.
44. Manabe N, Wong BS, Camilleri M, et al. Lower functional gastrointestinal disorders: evidence of abnormal colonic transit in a 287 patient cohort. Neurogastroenterol Motil 2010;22:293-e82.
45. Sadik R, Stotzer PO, Simrén M, et al. Gastrointestinal transit abnormalities are frequently detected in patients with unexplained GI symptoms at a tertiary centre. Neurogastroenterol Motil 2008;20:197-205. (Pubitemid 351197397)